GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Total Assets

Abbott Laboratories (Pakistan) (KAR:ABOT) Total Assets : ₨36,109 Mil (As of Mar. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Total Assets?

Abbott Laboratories (Pakistan)'s Total Assets for the quarter that ended in Mar. 2024 was ₨36,109 Mil.

During the past 12 months, Abbott Laboratories (Pakistan)'s average Total Assets Growth Rate was 11.40% per year. During the past 3 years, the average Total Assets Growth Rate was 22.00% per year. During the past 5 years, the average Total Assets Growth Rate was 15.40% per year. During the past 10 years, the average Total Assets Growth Rate was 16.40% per year.

During the past 13 years, Abbott Laboratories (Pakistan)'s highest 3-Year average Total Assets Growth Rate was 22.90%. The lowest was 6.70%. And the median was 12.35%.

Total Assets is connected with ROA %. Abbott Laboratories (Pakistan)'s annualized ROA % for the quarter that ended in Mar. 2024 was 16.69%. Total Assets is also linked to Revenue through Asset Turnover. Abbott Laboratories (Pakistan)'s Asset Turnover for the quarter that ended in Mar. 2024 was 0.44.


Abbott Laboratories (Pakistan) Total Assets Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Total Assets Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,752.68 24,915.74 28,567.75 33,919.80 36,693.45

Abbott Laboratories (Pakistan) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36,540.17 36,274.13 38,989.24 36,693.45 36,108.88

Abbott Laboratories (Pakistan) Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Abbott Laboratories (Pakistan)'s Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=18237.346+18456.099
=36,693

Abbott Laboratories (Pakistan)'s Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=19838.59+16270.292
=36,109

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories (Pakistan)  (KAR:ABOT) Total Assets Explanation

Total Assets is connected with ROA %.

Abbott Laboratories (Pakistan)'s annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=6075.04/( (36693.445+36108.882)/ 2 )
=6075.04/36401.1635
=16.69 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Abbott Laboratories (Pakistan)'s Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=16028.928/( (36693.445+36108.882)/ 2 )
=16028.928/36401.1635
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Abbott Laboratories (Pakistan) Total Assets Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines